Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • IOMICS Announces Innovative Data Analytics Platform for Chemical Engineering, Medical Research, and Clinical Care.

    May 10, 2016, 14:49 PM by Michael Croft
    BOSTON, MA - May 10, 2016 - IOMICS Announces Innovative Data Analytics Platform for Chemical Engineering, Medical Research, and Clinical Carex
    Full story
  • Rho to Discuss Clinical Trial Experience at American Pain Society 35th Annual Scientific Meeting 2016

    May 10, 2016, 13:06 PM by Michael Croft
    CHAPEL HILL, NC, UNITED STATES - May 10, 2016 -   WHAT:  Rho, a full-service contract research organization (CRO), will highlight its clinical trial expertise during the American Pain Society's (APS) 35th Annual Scientific Meeting, being held May 11-14 in Austin, Texas
    Full story
  • IBMs Watson is going to cybersecurity school

    May 10, 2016, 11:21 AM by Michael Croft
    Computerworld | The result will be a cloud service called Watson for Cyber Security that's designed to provide insights into emerging threats as well as recommendations on how to stop them.
    Full story
  • CRISPR Drug Maker Intellia Therapeutics Sells $108M In IPO Shares

    May 6, 2016, 10:06 AM by Michael Croft
    Xconomy | The latest biopharmaceutical company testing Wall Street's belief in the promise of gene modification has gone public. Intellia Therapeutics sold 6 million shares at $18 each to raise $108 million.
    Full story
  • Gene Therapy’s First Out-and-Out Cure Is Here

    May 6, 2016, 10:05 AM by Michael Croft
    MIT Technology Review | A genetic therapy for "bubble boy" disease completes a 27-year journey.
    Full story
  • The New Parasite Award Recognizes Secondary Analysis of Data

    May 5, 2016, 13:06 PM by Michael Croft
    STAT | The current incentives structure - mostly based on publishing in prestigious journals - discourages sharing, replication, and, some argue, careful science.
    Full story
  • Tech groups call on presidential candidates to support encryption embrace other IT issues

    May 5, 2016, 12:42 PM by Michael Croft
    Computerworld | U.S. presidential candidates should embrace encryption and narrow government access to Internet users' data as part of a comprehensive technology agenda, 13 IT trade groups recommended.
    Full story
  • How Blockchain Is Helping Genomics Research

    May 4, 2016, 10:50 AM by Michael Croft
    Bio-IT World | John Mattison predicts that blockchain, "is going to be the most disruptive technology in this space other than big-data analytics."
    Full story
  • The World’s Most Expensive Medicine Is a Bust

    May 4, 2016, 10:22 AM by Michael Croft
    MIT Technology Review | The first gene therapy approved in the Western world costs $1 million and has been used just once. The doctor who tried it says the price is "absolutely too high."
    Full story
  • IBM launches quantum computing for the rest of us

    May 4, 2016, 10:20 AM by Michael Croft
    Mashable | IBM unveiled the world's first cloud-based quantum computing experience. Starting today, anyone can access the quantum computing hardware based at IBM's T.J. Watson Research Center in Yorktown Heights, New York.
    Full story
  • Sinequa Ushers in The Era of Cognitive Computing with New Version of Its Cognitive Insight Platform

    May 3, 2016, 16:44 PM by Michael Croft
    NEW YORK, NY - May 3, 2016 - Sinequa today announced the general availability of Sinequa ES Version 10. Powered by Machine Learning capabilities at its core, this ground breaking version helps deliver deep analytics of contents and user behavior, offering information with continually improving relevance to users in their work environments
    Full story
  • This MIT employee redefined how universities launch startups

    May 3, 2016, 08:16 AM by Michael Croft
    STAT | Lita Nelsen of the Technology Licensing Office at MIT became an evangelist for tech transfer and a mentor to her counterparts around the world.
    Full story
  • Genomic Data and Drug Development EMA Offers New Draft Guidance

    May 2, 2016, 14:52 PM by Michael Croft
    RAPS | The European Medicines Agency has released a new draft guidance to provide industry with more insight on how to identify and understand genomic factors that influence drug responses.
    Full story
  • The Struggle With Image Glut

    May 2, 2016, 12:40 PM by Michael Croft
    Nature News & Comment | Experiments that generate millions of images have forced scientists to find new ways to store and share terabytes of experimental data.
    Full story
  • Three Pharma Data Challenges and How to Overcome Them

    Apr 29, 2016, 10:35 AM by Michael Croft

    Bio-IT World | Contributed Commentary | There’s no lack of ideas about what is needed to make advancements in life sciences research and improving patient care: real-time research, humanizing big data, enhancing customer values and motivation, and that’s just for starters. It was evident that these data struggles were on the minds of attendees at the recent Bio-IT World 2016 Conference in Boston.

    Full story
  • twoXAR Joins Stanford University in Hunt for Medicines Targeting Rare Diseases

    Apr 28, 2016, 10:53 AM by Michael Croft
    PALO ALTO, CA - Apr 28, 2016 -  twoXAR, Inc., a company dedicated to improving health through computation, today announced a collaboration with Joyce Teng, MD, PhD, of the Department of Dermatology at Stanford University to support research focused on the identification of drug candidates targeting rare disorders such as lymphatic malformation and epidermolysis bullosa simplex (EBS)
    Full story
  • AbbVie Buying Cancer Drug Startup Stemcentrx

    Apr 28, 2016, 10:18 AM by Michael Croft
    Fortune | AbbVie will buy Stemcentrx, which has five drugs targeting "cancer stem cells" in early clinical trials, for up to $10.2 billion in cash and stock.
    Full story
  • Emmanuelle Charpentier, the Quiet Revolutionary

    Apr 28, 2016, 10:16 AM by Michael Croft
    Nature News | The microbiologist spent years moving labs and relishing solitude. Then her work on gene-editing thrust her into the scientific spotlight.
    Full story
  • Certara Launches New E-learning Platform for Biosimulation Education

    Apr 28, 2016, 08:14 AM by Michael Croft
    PRINCETON, NJ - Apr 28, 2016 - Certara®, the global biosimulation technology-enabled drug development company, today launched an e-learning platform through Certara University to satisfy the increased need for education in the burgeoning field of biosimulation or model-based drug development
    Full story
  • Montrium Releases eTMF Navigator to Provide Greater Business Intelligence for Clinical Trials

    Apr 27, 2016, 16:43 PM by Michael Croft
    MONTREAL, QC, CANADA - Apr 28, 2016 - Montrium, clinical trial technology specialists, and electronic content management software providers, today, announced the commercial release of the eTMF Navigator, an interactive intelligence dashboard integrated into eTMF Connect
    Full story
  • «
  • 341
  • 342
  • 343
  • 344 (current)
  • 345
  • 346
  • 347
  • 348
  • 349
  • 350
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy